2m 2m 2m 2m 2m 2m 2m
NUVATION BIO-A (NUVB)
NYSE
$6.03+$0.27 (+4.60%)
Price as of Jun 23, 2026 7:10 PM EDT- $2.0BMarket Cap
- 183.74%1-Year Change
- BiotechnologyIndustry
NUVATION BIO-A (NUVB)
$6.03+$0.27 (+4.60%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 24.7M +213.26% | 7.9M N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | 7.1M N/A | N/A N/A | N/A N/A | |
Gross Profit | 24.7M +3,002.26% | 795,000 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | 856,000 -98.76% | 69.2M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -115.1M +16.13% | -99.1M +39.04% | -71.3M -18.82% | -87.8M +27.20% | |
Depreciation and Amortization Expense | 1.7M +154.61% | 683,000 +207.66% | 222,000 +11.56% | 199,000 +8.15% | |
Total Operating Expenses | 276.0M -53.50% | 593.4M +494.48% | 99.8M -16.63% | 119.7M +28.31% | |
Operating Profit | -213.1M -64.05% | -592.6M +493.68% | -99.8M -16.63% | -119.7M +28.31% | |
Interest Income | 21.4M -20.81% | 27.1M +9.96% | 24.6M +230.44% | 7.4M +151.37% | |
Interest Expense | -10.1M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 11.3M -58.27% | 27.1M +9.96% | 24.6M +230.44% | 7.4M +151.37% | |
Total Nonoperating Income and Expense | 8.4M -65.83% | 24.7M +2.78% | 24.0M +54.62% | 15.5M +140.11% | |
Income before Taxes | -204.6M -63.97% | -567.9M +649.24% | -75.8M -27.25% | -104.2M +19.98% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -204.6M -63.97% | -567.9M +649.24% | -75.8M -27.25% | -104.2M +19.98% | |
Net Income from Continuing Operations Applicable to Common | -204.6M -63.97% | -567.9M +649.24% | -75.8M -27.25% | -104.2M +19.98% | |
Basic EPS and Net Income | -0.60 -71.56% | -2.11 +502.86% | -0.35 -27.08% | -0.48 +9.09% | |
Diluted EPS and Net Income | -0.60 -71.56% | -2.11 +502.86% | -0.35 -27.08% | -0.48 +9.09% | |
Basic Weighted Average Shares | 341,541 +27.07% | 268,772 +22.79% | 218,880 +1.00% | 216,721 -99.89% | |
Diluted Weighted Average Shares | 341,541 +27.07% | 268,772 +22.79% | 218,880 +1.00% | 216,721 -99.89% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 164.1M +359.33% | 35.7M -16.24% | 42.6M -57.81% | 101.1M -23.65% | |
Short-Term Investments | 365.1M -21.81% | 467.0M -17.87% | 568.6M +1.54% | 559.9M -11.54% | |
Cash and Cash Equivalents and Short-Term Investments | 529.2M +5.28% | 502.7M -17.76% | 611.2M -7.53% | 661.0M -13.64% | |
Total Current Assets | 571.5M +8.60% | 526.3M -14.63% | 616.4M -7.63% | 667.3M -13.57% | |
Accumulated Depreciation | 1.2M +35.47% | 874,000 +31.23% | 666,000 +45.41% | 458,000 +57.39% | |
Property and Plant and Equipment and Net | 564,000 -3.75% | 586,000 -18.27% | 717,000 -19.80% | 894,000 +13.74% | |
Total Long-Term Assets | 7.6M +14.98% | 6.6M +1,027.09% | 587,000 -34.34% | 894,000 +13.74% | |
Total Assets | 594.8M +10.02% | 540.6M -13.01% | 621.5M -7.54% | 672.1M -13.40% | |
Income Taxes Payable | 45.5M +35.68% | 33.5M +237.24% | 9.9M +0.09% | 9.9M -20.82% | |
Total Short-Term Debt | 5.7M -8.90% | 6.3M +947.17% | 600,000 0.00% | 600,000 +20.00% | |
Total Current Liabilities | 82.2M +41.18% | 58.2M +316.80% | 14.0M +6.18% | 13.2M -22.24% | |
Total Long-Term Debt | 47.2M -81.12% | 250.0M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 148.4M +697.90% | 18.6M +678.64% | 2.4M -38.83% | 3.9M -70.49% | |
Total Liabilities | 289.1M +276.25% | 76.8M +369.61% | 16.4M -4.12% | 17.1M -43.41% | |
Retained Earnings | -1.1B +22.47% | -910.7M +165.67% | -342.8M +28.39% | -267.0M +64.00% | |
Total Stockholders Equity | 305.7M -34.08% | 463.8M -23.36% | 605.1M -7.63% | 655.1M -12.19% | |
Total Shares Outstanding | 337.8M 0.00% | 337.8M +54.23% | 219.0M +0.19% | 218.6M +0.31% | |
Cash Flow | |||||
Cash from Operating Activities | -173.4M +32.98% | -130.4M +91.79% | -68.0M -29.25% | -96.1M +40.94% | |
Capital Expenditures | 8.0M +4,838.27% | 162,000 +134.78% | 69,000 -81.35% | 370,000 +31.21% | |
Cash from Investing Activities | 99.5M -18.89% | 122.7M +1,275.44% | 8.9M -85.94% | 63.5M +113.96% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 202.5M +61,088.82% | 331,000 -47.29% | 628,000 -52.68% | 1.3M -99.79% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 10.10% N/A | N/A N/A | N/A N/A | |
Operating Margin | -863.90% -88.52% | -7,527.33% N/A | N/A N/A | N/A N/A | |
Return on Assets | -36.04% -63.12% | -97.74% +734.03% | -11.72% -18.55% | -14.39% -23.69% | |
Return on Equity | -53.18% -49.95% | -106.27% +783.32% | -12.03% -19.12% | -14.87% -35.69% | |
Revenue Growth | 213.26% N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 6.95 -23.08% | 9.04 -79.52% | 44.11 -13.00% | 50.70 +11.15% | |
Cash Ratio | 2.00 +225.35% | 0.61 -79.90% | 3.05 -60.27% | 7.68 -1.82% | |
Debt-to-Equity Ratio | 0.17 -68.68% | 0.55 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.09 -81.22% | 0.47 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow